Taming the Neuro ICU is an educational collaborative site for the growing specialty of NeuroCritical Care.
Under current guidelines, intravenous thrombolysis is used to treat acute stroke only if it can be ascertained that the time since the onset of symptoms was less than 4.5 hours.
Read MoreRecent literature has implicated severe neurologic injuries, such as aneurysmal subarachnoid hemorrhage, as a cause of cardiac dysfunction, impaired hemodynamic function, and poor outcomes.
Read MoreWe recognize the toll that caring for critically ill patients can take on a medical team, one that, in a different way, parallels the hardship faced by these patients and their families during such an ordeal. But we feel that patients like Mary, and family members like Mark, are what make our work most rewarding, especially when they can come back months later and show the success they’ve had in their recovery.
Read MoreWe sought to characterize the specialty classification of US physicians who provide critical care for neurological/neurosurgical disease. Physicians with a dedicated clinical neuroscience background accounted for less than half of neurocritical care service in US Medicare beneficiaries.
Read MoreChimeric antigen receptor T-cell therapy, a type of immune effector therapy for cancer, has demonstrated encouraging results in clinical trials for the treatment of patients with refractory hematologic malignancies. Nevertheless, there are toxicities specific to these treatments that, if not recognized and treated appropriately, can lead to multiple organ failure and death.
Read MoreTaming the NeuroICU is an educational and collaborative site for the growing specialty of Neuro Critical Care (NCC).
@ Copyright 2024 Department of Emergency Medicine, Division of Neurocritical Care, University of Cincinnati
